Illuminating role of CYP1A1 in skin function

Journal of Investigative Dermatology

Volumn 128, Issue 7, 2008, Pages 1866-1868

  Rowe, Jo M ^a   Welsh, Claire ^a   Pena, Romi N ^a   Wolf, C Roland ^b   Brown, Ken ^b   Whitelaw, C Bruce A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b CXR Biosciences Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; ENHANCED GREEN FLUORESCENT PROTEIN;

ACNE; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; CYP1A1 GENE; ENZYME ACTIVITY; ENZYME INDUCTION; GENE; GENE FUNCTION; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEBACEOUS GLAND; SEBUM; TRANSGENE; TRANSGENIC MOUSE;

EID: 45349105423     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701236     Document Type: Letter

References (8)

1. Behne M, Uchida Y, Seki T, de Montellano PO, Elias PM, Holleran WM (2000) Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function. J Invest Dermatol 114:185-92
2. Campbell SJ, Carlotti F, Hall PA, Clark AJ, Wolf CR (1996) Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation. J Cell Sci 109:2619-25
3. Katsuta Y, Iida T, Inomata S, Denda M (2005) Unsaturated fatty acids induce calcium influx into keratinocytes and cause abnormal differentiation of epidermis. J Invest Dermatol 124:1008-13
4. Nohara K, Ao K, Miyamoto T, Ito T, Suzuki T, Toyoshiba H et al. (2006) Comparison of the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced CYP1A1 gene expression profile in lymphocytes from mice, rats, and humans: most potent induction in humans. Toxicology 225:204-21
5. Paraskevaidis A, Drakoulis N, Roots I, Orfanos CE, Zouboulis CC (1998) Polymorphisms in the human cytochrome P-450 1A1 gene (CYP1A1) as a factor for developing acne. Dermatol 196:171-5
6. Pelclova D, Urban P, Preiss J, Lukas E, Fenclova Z, Navratil T et al. (2006) Adverse effects in human exposed to 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD). Rev Environ Health 21:119-38
7. Smith G, Ibbotson SH, Comrie MM, Dawe RS, Bryden A, Ferguson J et al. (2006) Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo. Br J Dermatol 155:275-81
8. Zouboulis CC (2004) Acne and sebaceous gland function. Clin Dermatol 22:360-6